Oxford Nanopore Technologies
Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
Latest Content
Product News
Oxford Nanopore Launches PromethION 2 Integrated Into Open Early Access
The PromethION 2 Integrated sets a new standard for convenience and efficiency in DNA, RNA, and cDNA sequencing. With its onboard computing capabilities, the self-contained device is bringing high-quality sequencing to a wider range of labs.
Webinar
Profiling Age and Body Fluid DNA Methylation Markers
On-Demand
In this webinar, our expert speaker will present a new approach – using nanopore adaptive sampling for comprehensive methylation profiling.
Product News
Lonza and Oxford Nanopore To Collaborate on Novel Test To Accelerate Analysis of mRNA Products
Collaboration aims to commercialize a Current Good Manufacturing Practice (cGMP) validated test to enable advanced and innovative analysis for multiple critical quality attributes of mRNA products.
Industry Insight
Shaping the Future of Genomic Medicine
In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
Product News
New State-of-the-Art Genomic Services Facility Opening in the UK
Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.
News
Compact DNA Sequencers Monitor Malaria Drug Resistance in Near Real-Time
Scientists have developed a technique to rapidly and reliably detect genetic changes in malaria parasites in Ghana, using just a gaming laptop and portable sequencer.
Product News
Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
Product News
Oxford Nanopore To Showcase What You’re Missing Matters When Investigating Disease Enabled by Nanopore Sequencing
Our packed agenda will highlight how the Oxford Nanopore platform can generate richer data revealing enhanced biological insights not possible with short read sequencing – or other sequencing platforms – to accelerate research into human disease.
Product News
Oxford Nanopore Technologies and Fabric Genomics Collaborate To Launch an Integrated Whole-Genome Sequencing Solution
The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings.
Product News
Oxford Nanopore Meets Apple’s M3 Silicon Chip
CEO Gordon Sanghera discusses how Apple’s latest product announcement means complex processing required for DNA/RNA sequencing can now be run from the latest MacBook Pro™ or iMac ™.
Advertisement
